Skip to main content
  • Home
  • Blogs
    • Access denied-living with multiple sclerosis
    • Enjoying the Ride
    • MS, CCSVI, Liberation Surgery & Me
    • The Cure for Multiple Sclerosis
    • Wheelchair Kamikaze
  • Research
    • By Author
        1. Paolo Zamboni
    • By Date
        1. 2012
        2. 2011
        3. 2010
        4. 2009
        5. 2008
        6. 2007
    • By Keyword
  • Video
  • Contact
  • About
MS-Info.ca logo

MS-Info.ca

Important Scientific Information about Multiple Sclerosis

You are here

  1. Home

CD86

Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling

Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE. Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. J Neuroimmunol [Internet]. 2007;188:103-116. Available from: http://www.hubmed.org/display.cgi?uids=17614141

PubMed: 

  • interferon-beta
  • interferon-beta
  • phenotypic profiling
  • phenotypic profiling
  • pharmacodynamic
  • pharmacodynamic
  • neutrophils
  • neutrophils
  • B cells
  • B cells
  • CD4 T
  • CD4 T
  • CD8 T
  • CD8 T
  • HLA class II
  • HLA class II
  • CCR5
  • CCR5
  • CD38
  • CD38
  • CD40
  • CD40
  • CD54
  • CD54
  • CD64
  • CD64
  • CD69
  • CD69
  • CD86
  • CD86
  • CD101
  • CD101
  • TLR2
  • TLR2
  • TLR4
  • TLR4
  • MCP2
  • MCP2
  • drug formulation
  • drug formulation
  • dosing
  • dosing
  • bioequivalence
  • bioequivalence

Taxonomy upgrade extras: 

  • two-photon-excitation fluorescence
  • Read more about Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling
  • Google Scholar
Subscribe to CD86

Monthly archive